Journal Title：Hla

HLA publishes full-length original articles, brief communications, commentaries and reviews covering all aspects of genetic control of immunity. The scope includes functional, biochemical, and genetic studies on molecules of the immune system, including cell surface receptors and their ligands, and encompassing cytokines, and chemokines, adhesion and co-stimulating molecules, antigen receptors such as TcR, NKR, CD1, PAMPs, Igs, KIR, and genes and products of the major histocompatibility complex including classical and non-classical HLA molecules. Papers should describe original research in vitro, or in animal models, or be clinical studies reflecting genetics of immunity in solid organ or haematopoietic stem cell transplantation, autoimmunity, infectious immunity, allergy, tumour immunity, vaccine science, pregnancy and disease susceptibility.

HLA 出版涵蓋免疫遺傳控制各個方面的全篇原創(chuàng)文章、簡訊、評論和綜述。范圍包括免疫系統(tǒng)分子的功能、生化和遺傳研究，包括細胞表面受體及其配體，以及細胞因子和趨化因子、粘附和共刺激分子、抗原受體（如 TcR、NKR、CD1、PAMP、Igs、KIR）以及主要組織相容性復合體（包括經(jīng)典和非經(jīng)典 HLA 分子）的基因和產(chǎn)物。論文應描述體外或動物模型中的原創(chuàng)研究，或為反映實體器官或造血干細胞移植、自身免疫、感染性免疫、過敏、腫瘤免疫、疫苗科學、妊娠和疾病易感性等免疫遺傳學的臨床研究。

Hla創(chuàng)刊于2016年，由Wiley-Blackwell Publishing Ltd出版商出版，收稿方向涵蓋Immunology and Microbiology - Immunology全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 ，影響因子指數(shù)5.9，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。